Pliant Therapeutics Presents Data from its Bexotegrast Progr

SOUTH SAN FRANCISCO, Calif., May 21, 2024 -- Pliant Therapeutics, Inc. , a clinical-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment...

Related Keywords

United States , California , American , Jonathang Goldin , Martinl Decaris , Christopher Keenan , Los Angeles , Gregoryp Cosgrove , Drug Administration , American Thoracic Society , International Conference , Pliant Therapeutics Inc , European Medicines Agency , Corporate Communications , David Geffen School Of Medicine , Clinical Development At Pliant Therapeutics , Linkedin , Development For Idiopathic Pulmonary Fibrosis , Nasdaq , Facebook , University Of California , Translational Sciences At Pliant , Youtube , Chief Medical Officer , Dual Selective Inhibitor , Idiopathic Pulmonary Fibrosis , Primary Sclerosing , Vice President , Clinical Development , Pliant Therapeutics , Specific Cell Types , Fibrotic Human , Principal Scientist , Interstitial Lung Disease Progression , Senior Director , Translational Sciences , Quantitative Imaging , Biomedical Physics , David Geffen School , Fast Track Designation , Orphan Drug Designation , Media Contact , Investor Relations ,